Erythrocyte superoxide dismutase activity in patients with malignant neoplasms.
Erythrocyte superoxide dismutase activity was determined in four groups of patients, two with hematologic neoplasms with and without therapy and two others with solid tumors also selected on the basis of therapy. Increased activities were found in the two groups where there was no treatment, whereas those under treatment showed normal levels. In addition, an inverse relationship (r = -0.25 p < 0.02) between superoxide dismutase activities and the time under therapy was observed.
Franco
M E
ME
Div. de Genética, Subjefatura de Invest. Científica, Unidad de Invest. Biomédica, CMO, IMSS, Guadalajara, Jalisco, México.
Carrillo
M C
MC
Hernández
C
C
Medina
C
C
Ibarra
B
B
Vaca
G
G
Cantú
J M
JM
D000328:Adult; D004912:Erythrocytes / Q000201:enzymology*; D006801:Humans; D007938:Leukemia / Q000097:blood; D008223:Lymphoma / Q000097:blood; D009363:Neoplasm Proteins / Q000097:blood*; D009369:Neoplasms / Q000201:enzymology* / Q000628:therapy; D011897:Random Allocation; D013482:Superoxide Dismutase / Q000378:metabolism*
D009363:Neoplasm Proteins; D013482:Superoxide Dismutase